Home > Clinical & Pharmacy
Web Content Viewer
Web Content Viewer
Quantity limits increased on generics of Adderall XR, Concerta
April 28, 2023

This article is for providers who prescribe amphetamine/dextroamphetamine ER capsules (generic Adderall XR) and methylphenidate hydrocholoride ER tablets (generic Concerta)

To give providers greater flexibility when prescribing the generic medications listed below given the recent supply shortages, we have decided to increase the quantity limit that we’ll cover. This also helps reduce prescribers' administrative burden.

The change took effect April 12, 2023 and we plan to maintain the new limit even after the manufacturers’ shortages are addressed. It applies to commercial members with health plans that include prescription coverage and who use our Blue Cross formulary.

As you know, because these are controlled substances, a new prescription is required with each refill whether you are adjusting the quantity or not.

New covered quantity limit
The following medications are covered for up to 60 units for a 30-day supply:

  • amphetamine/dextroamphetamine capsules, extended release (5 mg, 10 mg, 15 mg, 25 mg)
  • methylphenidate hydrochloride tablet, extended release (18 mg, 27 mg, 54 mg)

The following medications will be covered for up to 120 units for a 30-day supply:

  • amphetamine/dextroamphetamine capsules, extended release (20 mg, 30 mg)
  • methylphenidate hydrochloride tablet, extended release (36 mg)

Questions?
Contact Pharmacy Operations at 1-800-366-7778.

MPC_040623-1J-1-ART